The FLG gene (encoding filaggrin, a barrier-related molecule) in our cohort exhibited a higher frequency of mutations than that in previous studies (28% vs. 4%) [89]; however, the function of FLG in NB is still unknown. The gene discussed is FLG; the disease is neuroblastoma.